Candida krusei– a serious complication in patients with hematological malignancies: successful treatment with caspofungin
✍ Scribed by A. Conen; M. Weisser; C. Orasch Jörg; M. Battegay; A. Trampuz; R. Frei; S. Christen; D. Heim; A. Gratwohl; U. Flückiger
- Book ID
- 110904157
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 334 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1398-2273
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. ## METHODS. Patients with proven or probable IA were randomized in a
## Abstract ## BACKGROUND Caspofungin (CAS) as salvage therapy for refractory invasive aspergillosis (IA) had a response rate of 45% among a heterogeneous group of patients. The use of CAS with other agents is appealing given its unique mechanism of action. Therefore, the authors retrospectively e